跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LETROZOLE ACTAVIS 2.5mg - TGA Drug Approval Details
Approvals
/
TGA
/
LETROZOLE ACTAVIS 2.5mg
Approved
STANDARD
LETROZOLE ACTAVIS 2.5mg
Medis Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b340eb145022b53e
Company
Medis Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
b340eb145022b53e
Product Name
LETROZOLE ACTAVIS 2.5mg
Artg Id
176276
Artg Name
LETROZOLE ACTAVIS 2.5mg letrozole 2.5mg tablet blister pack
Sponsor
Medis Pharma Pty Ltd
Company Detail Path
/organization/medis-pharma-pty-ltd
Artg Date
2011-09-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2952fcf7f7c64ca328ac5733bcc30a59.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/79a079a19814384b73b4a991175b7c0e.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b340eb145022b53e
Type
Standard
Back to TGA Approvals